Tirzepatide ZPHC — 30 mg Premixed Pen

Tirzepatide — dual GLP-1 / GIP receptor agonist
30 mg pre-filled aqueous pen • 60 clicks × 0.5 mg
Ready to use: fully dissolved peptide — no vials or mixing; just dial, click and inject sub-Q.
Dual-incretin power: combined GLP-1 & GIP activation delivers superior appetite suppression, improved insulin sensitivity and rapid fat-loss.
Micro-precision dial: each click dispenses 0.5 mg; transparent window shows remaining volume.
Suggested research titration: 0.5 mg weekly → increase by 0.5 mg every 4 weeks up to 5 mg (10 clicks) as tolerated.
Storage: ship on ice; refrigerate 2 – 8 °C after opening; stable 30 days at 2 – 8 °C.
QC: ≥ 99 % purity, endotoxin < 0.03 EU/mg; pen sterilised and tamper-evident with scratch-code authenticity., Tirzepatide ZPHC — 30 mg Premixed Pen, 229, USD, ,